OREANDA-NEWS. October 29, 2015. Motif Bio plc (AIM:MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has been selected to present at BIO-Europe, a leading European pharmaceutical-biotechnology conference. The CEO of Motif, Graham Lumsden, will present.

Presentation dates:

The BIO-Europe 2015 conference on November 2 through November 4, 2015 at the International Congress Center (ICM) in Munich, Germany. Motif will be presenting at 16:45 CET on November 3 in Room 2, Level 0.